Identified a new repairing mechanism of the peripheral nervous system by applyting bioengineering techniques Blog Post

A research group at the Institute of Bioengineering of Catalonia (IBEC) at the Barcelona Science Park has applied a new light-stimulated technique to modulate muscular activity and stimulate cell regeneration of the peripheral nervous system. Thanks to this research, published in Cells, the scientists have discovered that muscle activity can activate the neurons and accelerate their regeneration after an injury. 

 

AVX pharma announces initiation of a Phase 2 Clinical Trial of AVX-012 Ophthalmic Solution in Dry Eye Syndrome Blog Post

Avizorex Pharma (AVX Pharma), a clinical stage biopharmaceutical company with offices at Barcelona Science Park and focused on the development of novel therapies for Dry Eye Syndrome, today announced the initiation of a Phase 2 clinical trial, evaluating the safety and efficacy of AVX-012 Ophthalmic Solution in patients with mild-to-moderate Dry Eye Syndrome, based on the concept of modulating corneal nerve activity to stimulate basal lacrimation.